Schedule of basic and diluted per share results



	For the Three Months Ended
	March 31, 2022		March 31, 2021
Net income (loss)	$	269	$	(768)

Weighted average shares outstanding for computation of basic per share results		10,185,000		6,236,000
Incremental shares from assumed exercise of stock options and warrants and the grant of restricted stock units (a)		236,000		—
Adjusted weighted average shares for computation of diluted per share results		10,421,000		6,236,000

(a)

Incremental shares from the assumed exercise of INDUS stock options are not included in periods where the inclusion of such shares would be anti-dilutive. The incremental shares from the assumed exercise of stock options for the first quarter of 2021 would have been 95,000. For the first quarter of 2021, there was also a Warrant for the purchase of 515,747 shares of Common Stock that was anti-dilutive.

Schedule of option holders


Number of option holders at March 31, 2022		14

Schedule of options by range of exercise prices


				Weighted Avg.
				Remaining
Range of Exercise Prices for	Outstanding at	Weighted Avg.		Contractual Life	Total Intrinsic
Outstanding Options	March 31, 2022	Exercise Price		(in years)	Value
$23.00 - $28.00	81,987	$	26.23	4.0	$	3,842
$28.00 - $32.00	14,073	$	29.84	3.3		609
$32.00 - $47.00	124,877	$	43.93	7.7		3,641
	220,937	$	36.47	6.0	$	8,092

Vested options	111,258	$	28.13	4.2	$	5,002

Schedule of compensation expense and related tax benefits for stock options

Summary of activity for restricted stock units


	Time-based vesting
	March 31, 2022			March 31, 2021
	Number of		Weighted Avg.	Number of		Grant Date
	Units		Exercise Price	Units		Fair Value
Outstanding at beginning of period	12,829	$	64.43	—	$	-
Granted	7,991	$	76.71	8,508	$	63.15
Adjustment for dividends	26	$	-	—	$	-
Vested and distributed	(2,718)	$	63.15	—	$	-
Forfeited	(813)	$	63.15	—	$	-
Outstanding at end of period	17,315	$	70.26	8,508	$	63.15

Summary of activity for restricted stock units


	Performance-based vesting
	March 31, 2022			March 31, 2021
	Number of		Weighted Avg.	Number of		Grant Date
	Units		Exercise Price	Units		Fair Value
Outstanding at beginning of period	8,136	$	78.97	—	$	-
Granted	7,999	$	100.19	8,508	$	79.33
Adjustment for dividends	16	$	-	—	$	-
Forfeited	(1,219)	$	79.33	—	$	-
Outstanding at end of period	14,932	$	90.22	8,508	$	79.33

For the Three Months Ended

March 31, 2022

March 31, 2021

Compensation expense